Nephrocare Health Services Ltd
Q1 FY27, unaudited
- Revenue
- ₹281.75 Cr
- Profit after tax
- ₹31.97 Cr
As filed with the exchange, consolidated basis.
Statement of profit and loss
Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.
| ₹ crore | Q1 FY27 | vs a year ago | FY26 |
|---|---|---|---|
| Revenue from operations | 281.75 | — | 998.85 |
| Other income | 7.46 | — | 24.51 |
| Total income | 289.21 | — | 1,023.36 |
| Employee benefit expense | 47.83 | — | 171.79 |
| Finance costs | 2.21 | — | 60.24 |
| Depreciation & amortisation | 24.54 | — | 90.67 |
| Total expenses | 244.62 | — | 922.79 |
| Profit before tax | 44.60 | — | 100.57 |
| Tax expense | 9.06 | — | 20.63 |
| Profit after tax | 31.97 | — | 76.84 |
| Total comprehensive income | 33.05 | — | 95.47 |
| Earnings per share, basic | ₹3.19 | ₹8.48 |
|---|---|---|
| Earnings per share, diluted | ₹3.11 | ₹8.10 |
Q1 FY27 — unaudited, from the company’s filing with NSE. Source
FY26 — from the company’s filing with NSE. Source
Why the dash
Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.
Earnings call
Q4 FY26Nephrocare Health Services (NephroPlus) reported FY26 revenue growth of 32% to Rs 998.8 crore and adjusted EBITDA growth of 37% to Rs 238.2 crore, with adjusted PAT up 75%. Management attributed growth to same-clinic ramp-up, new clinic rollouts in India and overseas, and a rising mix of international revenue, while flagging a one-time Rs 10 crore expected credit loss provision that reduced Q4 margins. The company also discussed its expansion plans in the Philippines, Uzbekistan and Saudi Arabia, and reiterated a medium-term revenue growth framework.
Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary
Filings
12 shown · 55 published by the exchange
19 Aug 2026
Transcript17 Aug 2026
13 Aug 2026
13 Aug 2026
13 Aug 2026
12 Aug 2026
Filing12 Aug 2026
12 Aug 2026
11 Aug 2026
Filing11 Aug 2026
11 Aug 2026
11 Aug 2026
Presentation
BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.
Page generated from filings held to 19 Aug 2026.